top of page
investors_hero.jpg

Our Communities

Investors

We envision a world where cancer is overcome by early and informed treatment. To transform cancer care by profiling cancer to its furthest limits, we invent ultrasensitive blood-testing technology for early cancer detection and treatment selection.

Our Strategic Collaborator

Our Lead Investors

Openspace - Colour - 387x180.png
IHH- Colour - 280x180.png
SGInnovate - Colour - 232x180.png
Heliconia - Colour - 480x88.png

Our Solutions

Scroll for more →

Hereditary Risk Assessment

Purpose

Cancer # or type

Sample Requirements

Hereditary cancer risk assessment

LumiRISK™: breast, ovarian, endometrial, pancreas, colorectal, prostate, lung, gastric, kidney, thyroid, melanoma

LumiTHERA™: breast, ovarian, endometrial, pancreas, colorectal, prostate

LumiFOCUS™: specific hereditary cancers

2 tubes blood

Available internationally outside the USA.

Scroll for more →

​Screening and Health Risk Assessment

Purpose

Cancer # or type

Sample Requirements

Multi-Cancer Early Detection (MCED)

Up to 50 cancers

2-3 tubes blood

Cardiac and hematological risk assessment

Assesses risk of heart attack, stroke, leukemia

2 tubes blood

LucenceLONGEVITY™: LucenceINSIGHT® 50 + CardioHemeRISK™

Available internationally outside the USA.

Scroll for more →

Treatment Response Monitoring

Purpose

Cancer # or type

Sample Requirements

Recurrence & drug response monitoring

6 solid tumors: lung, breast, colon, liver, pancreas, bile duct

3 tubes blood

Available internationally outside the USA.

Scroll for more →

Treatment Selection

Purpose

Cancer # or type

Sample Requirements

Comprehensive multi-cancer blood test for therapy selection

Solid tumors

2-3 tubes blood

Tumor-targeted blood test for therapy selection

Lung, breast, ovarian, colon, prostate, pancreas, bile duct

3 tubes blood

EGFR mutation blood test for therapy selection in NSCLC

Lung cancer

3 tubes blood

Hematological cancer test for therapy selection

Blood cancers

2 tubes blood and/or
1 tube bone marrow aspirate

Nasopharyngeal cancer early screening

Nasopharyngeal Carcinoma (NPC)

1 tube blood

Comprehensive multi-cancer tissue test for therapy selection and diagnosis

Solid tumors

15 slides tissue

Brain and CNS tissue test for tumor classification, therapy selection and diagnosis

CNS cancers

15 slides tissue

Tumor-targeted tissue test for therapy selection and diagnosis

7 solid tumors: lung, breast, ovarian, colon, prostate, pancreas, bile duct

15 slides tissue

Available internationally outside the USA.
*Available internationally including the USA.

Scroll for more →

Interested in partnering with us to advance precision medicine? Let’s start the conversation.

bottom of page